Salivary gland parameters and clinical data related to the underlying disorder in patients with persisting xerostomia

European Journal of Oral Sciences

Volumn 115, Issue 2, 2007, Pages 97-102

  Van Berg, Ianthe Den ^a   Pljpe, Justin ^a   Vissink, Arjan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Medication; Salivary gland function; Sialosis; Sj gren's syndrome; Xerostomia

Indexed keywords

POTASSIUM; SODIUM;

ARTICLE; CHEMISTRY; CHI SQUARE DISTRIBUTION; DRUG EFFECT; HUMAN; NONPARAMETRIC TEST; PATHOLOGY; QUESTIONNAIRE; SALIVA; SALIVARY GLAND DISEASE; SALIVATION; SIALOGRAPHY; SJOEGREN SYNDROME; XEROSTOMIA;

CHI-SQUARE DISTRIBUTION; HUMANS; POTASSIUM; QUESTIONNAIRES; SALIVA; SALIVARY GLAND DISEASES; SALIVATION; SIALOGRAPHY; SJOGREN'S SYNDROME; SODIUM; STATISTICS, NONPARAMETRIC; XEROSTOMIA;

EID: 34247476878     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/j.1600-0722.2007.00432.x     Document Type: Article

References (31)

1. MANDEL ID. The diagnostic uses of saliva. J Oral Pathol Med 1990; 19: 119-125.
2. ATKINSON JC, WU AJ. Salivary gland dysfunction: causes, symptoms, treatment. JADA 1994; 125: 409-416.
3. SCULLY C. Drug effects on salivary glands: dry mouth. Oral Dis 2003; 9: 165-176.
4. PORTER SR, SCULLY C, HEGARTY AM. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radial Endod 2004; 97: 28-46.
5. MIGNOGNA MD, FEDELE S, Lo Russo L, Mo Muzio L, WOLFF A. Sjögren's syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xcrostomia. J Oral Pathol Med 2005; 34: 1-6.
6. KALK WWI, VISSINK A, SPUKERVET FKL, BOOTSMA H, KALLENBERG COM, NIEUW AMERONGEN AV. Sialometry and sialochemistry: diagnostic tools for Sjogren's syndrome. Ann Rheum Dis 2001; 60: 1110-1116.
7. KALK WWI, VISSINK A, STEGENGA B, BOOTSMA H, NIEUW AMERONGEN AV, KALLENBERG CGM. Sialometry and sialochemistry: a non-invasive approach for diagnosing Sjogren's syndrome. Ann Rheum Dis 2002; 61: 137-144.
8. Fox RI. Sjögren's syndrome. Lancet 2005; 366: 321-331.
9. CHTLLA R, ARGLEBE CH. Function of salivary glands and sialochemistry in sialadcnosis. Acta Otorhinolaryngol 1983; 73: 158-164.
10. BATASAKIS JG. Pathology consultation sialadenosis. Ann Otol Rhinol Laryngol 1988; 97: 94-95.
11. MANDEL L, HAMELE-BENA D. Alcoholic parotid sialadenosis. JADA 1997; 128: 1411-1415.
12. KIM D, UY C, MANDEL L. Sialosis of unknown origin. N Y State Dent J 1998; 64: 38-40.
13. MANDEL L, PATEL S. Sialadenosis associated with diabetes mellitus: a case report. J Oral Maxillofac Surg 2002; 60:696-698.
14. MANDEL L, VAKKAS J, SAQI A. Alcoholic (beer) sialosis. J Oral Maxillofac Surg 2005; 63: 402-405.
15. GUPTA A, EPSTEIN JB, SROUSSI H. Hyposalivation in elderly patients. J Can Dent Assoc 2006; 72: 841-846.
16. MALAMUD D. Salivary diagnostics. The future is now. J Am Dent Ansoc 2006; 137: 284-285.
17. VITALI C, BOMBARDIERI S, JONSSON R, MOUTSOPOULOS HM, ALEXANDER EL, CARSONS SE, DANIELS TE, FOX PC, FOX RI, KASSAN SS, PILLEMER SR, TALAL N, WEISMAN MH. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-558.
18. KALK WWI, VISSINK A, SPLIKERVET FKL, KALLENBERG CGM, ROODENBURG JLN. Parotid sialography for diagnosing Sjogren syndrome. Oral Surg Oral Med Oral Pathol Oral Radial Endod 2000; 94: 131-137.
19. INO C, MATSUYAMA K, INO M, YAMASHITA T, KUMAZAWA T. Approach to the diagnosis of sialadenosis using sialography. Acta Otolaryngol 1993; 500: 121-125.
20. BENEDEK-SPÄT E. Sialochemical examinations in non-tumorous parotid enlargements. Acta Otolaryngol 1978; 86: 276-282.
21. MEYER P, WERNER E. Sialochcmische Untersuchungen an den isolierten Sekreten der grossen Kopfspeicheldrüsen. Laryngorhinootologie 1994; 73: 472-477.
22. MICHELS LFE. Sialometry and sialochemistry. In: GRAAMANS K, VAN DEN AKKER HP, eds. Diagnosis of salivary gland disorders, Dordrecht: Kluwer Academic, 1991; 139-161.
23. SCHUBERT MM, IZUTSU KT. Iatrogenic causes of salivary gland dysfunction. J Dent Res 1987; 66: 680-688.
24. KALK WWI, MANSOUR K, VISSINK A, SPIJKERVET FKL, BOOTSMA H, KALLENBERG COM, ROODENBURG JLN, NIEUW AMERONGEN AV. Oral and ocular manifestations in Sjogren's syndrome. J Rheumatol 2002; 29: 924-930.
25. PIJPE J, KALK WWI, BOOTSMA H, SPUKERVET FKL, KALLENBERG COM, VISSINK A. Progression of salivary gland dysfunction in patients with Sjögren's syndrome. Ann Rheum Dis 2007; 66: 107-112.
26. ATKINSON JC. The role of salivary measurements in the diagnosis of salivary autoimmune diseases. Ann N Y Acad Sci 1993; 694: 238-251.
27. HELENUS LM, MEURMAN JH, HELENIUS I, KARI K, HIETANEN J, SUURONEN R, HALLIKAINEN D, KAUTIANINEN H, LEIRISALOREPO M, LINDQVIST C. Oral and salivary parameters in patients with rheumatic diseases. Acta Odontol Scand 2005; 63: 284-293.
28. PEDERSEN AM, BARDOW A, NAUNTOFTE B. Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sjögren's syndrome. BMC Clin Pathol 2005; 5: 4.
29. RAUCH S. Natriumretinierende sialose. Arch Klin Exp Ohren Nanen Kehlkopfheilkd 1967; 188: 525-528.
30. LICHTE JR, MULDER AW, MICHELS LFE. Parotid gland dysfunction in haemodialysis patients. Ned J Med 1983; 26: 39-43.
31. SHANNON IL, FELLER RP, EKNOYAN G, SUDDICK RP. Human parotid saliva urea in renal failure and during dialysis. Arch Oral Biol 1977; 22: 83-86.